The melanoma cancer cell lines (B16 and A375) express the endocannabinoid receptors CB1 and CB2 [1,86], the CBD-dependent activation of which has decreased melanoma growth proliferation, angiogenesis, and metastasis in vivo. The gene discussed is CNR1; the disease is melanoma.